Edgestream Partners’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,796
Closed -$461K 1070
2024
Q4
$461K Buy
12,796
+7,791
+156% +$264K 0.02% 702
2024
Q3
$212K Sell
5,005
-5,047
-50% -$214K 0.01% 803
2024
Q2
$405K Buy
+10,052
New +$419K 0.02% 700

Other funds holding TNDM

Edgestream Partners's TNDM Position: Q1 2025 in Review

Edgestream Partners sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 12,796 shares — an estimated $461K sold.

Edgestream Partners first reported a position in TNDM in Q2 2024 and held it in 3 quarters. The position peaked at $461K in Q4 2024. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Edgestream Partners reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Edgestream Partners sold 12,796 Tandem Diabetes Care shares in Q1 2025, an estimated $461K.
  • Edgestream Partners first reported a position in Tandem Diabetes Care in Q2 2024 and held it in 3 quarters.
  • Edgestream Partners's Tandem Diabetes Care position peaked at $461K in Q4 2024.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Edgestream Partners's 13F filing for Q1 2025, filed 2 May 2025.